Thailand develops robotic system to squeeze out more vaccine doses
Send a link to a friend
[August 25, 2021]
By Juarawee Kittisilpa
BANGKOK (Reuters) - As Thailand struggles
with its worst coronavirus outbreak yet, researchers in the country have
developed a machine to draw out COVID-19 vaccine doses more efficiently
and optimise lower-than-expected supplies.
Using a robotic arm, the "AutoVacc" system can draw 12 doses of the
AstraZeneca vaccine in four minutes from a vial, according to
researchers at Chulalongkorn University, who made the machine that has
been used at the university's vaccination centre since Monday.
That is up 20% from the standard 10 doses drawn manually, they said. The
machine only works on AstraZeneca multi-dose vials currently and labels
show each vial can provide 10 to 11 doses.
"The machine guarantees with accuracy that we can gain an extra 20% from
each vaccine vial - from 10 to 12 doses," said Juthamas Ratanavaraporn,
the lead researcher of the team at the university's Biomedical
Engineering Research Center. "The extra 20% that we get means that if we
have AstraZeneca for 1 million people, this machine can increase the
number of doses to 1.2 million people," said Juthamas.
While some health workers using low dead space syringes (LDSS) that aim
to reduce wastage can draw up to 12 doses per vial, it requires manpower
and a high level of skill, she said.
"This could drain a lot of the health workers' energy. They would have
to do this every day for many months," Juthamas said.
Thailand had kept COVID-19 largely under control for much of the
pandemic, but more virulent variants like Delta have sent cases and
deaths soaring since April, ramping up pressure on authorities to
increase the pace of vaccinations.
So far, around 9% of Thailand's population of more than 66 million have
been fully vaccinated, with the rollout hindered by
lower-than-anticipated vaccine supplies.
[to top of second column]
|
A vaccine extraction machine called AutoVacc, designed by the
Chulalongkorn University's Biomedical Engineering Research Center to
extract extra doses out of AstraZeneca vaccine vials, is seen in
Bangkok, Thailand August 23, 2021. Picture taken August 23, 2021.
REUTERS/Juarawee Kittisilpa
The research team say they should be able to produce
20 more AutoVacc units within three or four months, but that
government funds and support would be needed to expand across the
country.
The prototype machine costs 2.5 million baht ($76,243), including
other materials like syringes, said Juthamas, adding that while they
were open to export opportunities, that was something for the
future.
They also plan to make similar machines to use with the Pfizer-BioNTech
and Moderna vaccines, she added.
Juthamas said the machine was aimed at removing burdens on health
workers. Thailand has reported around 1.1 million COVID-19
infections and 10,085 deaths in total, pushing parts of the health
system to the brink.
"When the health workers are too tired, there are also chances of
human error, so we should let the machines work on this," she said.
($1 = 32.7900 baht)
(Writing by Ed Davies; Editing by Ana Nicolaci da Costa)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|